← 返回

非吸烟与非饮酒者口腔鳞状细胞癌中 PD-L1 频繁表达及 TIL(肿瘤浸润淋巴细胞)与良好预后的相关性

英文原题:Frequent PD-L1 expression in oral squamous cell carcinoma of non-smokers and non-drinkers, and association of tumor infiltrating lymphocytes with favorable prognosis.

查看英文原题

Frequent PD-L1 expression in oral squamous cell carcinoma of non-smokers and non-drinkers, and association of tumor infiltrating lymphocytes with favorable prognosis.

PubMed 2025/03/15(内容时间) Transl Oncol Q2 · IF 4.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

大量 NSND 中的 OSCC 显示 PD-L1 表达(CPS 1)。CD4 是 DFS 和 OS 的显著预测因子,此外 CD8/FoxP3 比值是 OS 的近显著预测因子。PD-L1 阳性肿瘤中频繁高 CD8 阳性 TIL 浸润的组合,使 NSND 合并 OSCC 在理论上成为免疫检查点抑制剂治疗的有趣候选者。

研究思路结论见上方概要

确定PD-L1和PD-L2表达以及TIL(肿瘤浸润淋巴细胞)(TILs)在非吸烟者和非饮酒者(NSND)口腔鳞状细胞癌(OSCC)中的存在情况及预后价值。

回顾性收集并分析86例NSND合并OSCC患者的临床特征和肿瘤组织,在组织微阵列上检测蛋白表达。采用免疫组化检测PD-L1 CPS、PD-L2 TPS以及PD-1、CD45、CD8、CD4、CD3和FoxP3阳性TILs/mm²的表达。使用QuPath对切片进行数字化评估。通过log rank分析确定5年DFS和OS的差异。通过多因素cox回归分析确定生存预测因素。

88% (76/86) 的 OSCC 显示 PD-L1 表达 (CPS 1)。CD4 阳性 TIL 数量高的患者比 CD4 阳性 TIL 数量低的患者表现出更好的 DFS 和 OS。在最佳多变量模型中,CD4 阳性 TIL 也是 DFS (p = 0.010) 和 OS (p = 0.002) 的独立预测因子。此外,CD45 阳性 TIL 数量高且 CD8/FoxP3 比值高的患者表现出更好的 OS,其中 CD8/FoxP3 比值是一个接近显著的独立预测因子 (p = 0.050)。超过 40% 的 OSCC 为 PD-L1+/TIL+。

展开英文摘要原文

To determine the presence and prognostic value of PD-L1 and PD-L2 expression, and tumor-infiltrating lymphocytes (TILs) in oral squamous cell carcinoma (OSCC) of non-smokers and non-drinkers (NSND).

Clinical characteristics and tumor tissue of 86 NSND with OSCC were retrospectively collected and analyzed for protein expression on tissue microarrays. Immunohistochemistry was performed for expression of PD-L1 CPS, PD-L2 TPS, and PD-1, CD45, CD8, CD4, CD3, and FoxP3-positive TILs/mm 2 . Slides were digitally evaluated using QuPath. Differences in 5-year DFS and OS were determined by log rank analysis. Predictors for survival were determined by multivariable cox regression analysis.

Eighty-eight percent (76/86) of OSCC showed PD-L1 expression (CPS 1). Patients with high numbers of CD4-positive TILs showed a better DFS and OS than patients with low numbers of CD4-positive TILs. In the best multivariable model, CD4-positive TILs were an independent predictor for DFS (p = 0.010) and OS (p = 0.002) too. Additionally, patients with high numbers of CD45-positive TILs and a high CD8/FoxP3 ratio showed a better OS, of which the CD8/FoxP3 ratio was a near significant independent predictor (p = 0.050). Over 40 % of OSCC were PD-L1+/TIL+.

A large number of OSCC in NSND show PD-L1 expression (CPS 1). CD4 was a significant predictor for DFS and OS, in addition to the CD8/FoxP3 ratio being a near significant predictor for OS. The combination of frequent high CD8-positive TIL infiltrates in PD-L1-positive tumors makes NSND with OSCC in theory interesting candidates for treatment with immune checkpoint inhibitors.

论文信息

作者
Mulder FJ、de Ruiter EJ、Gielgens T、Farshadpour F、de Bree R、van den Hout M、Kremer B、Willems SM
单位
Department of Otorhinolaryngology and Head & Neck Surgery, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands. Electronic address: frans.mulder@mumc.nl.Netherlands
期刊
Translational oncology2025 May
原文标识
PubMed 40090069 · DOI 10.1016/j.tranon.2025.102357